I think it would help if we add some big pharma top management to the team to establish credibility , a well known PR firm to streamline news and follow up/ meet promises in previous PR's. Because delays in listing the increased float (divi) is hurting the current pps. So far we have not been successful to unlock the value of our "gold" and no guarantees in the near future. If the Coronavirus plan is not executed efficiently we will miss that boat too !!!